CardioNet LLC’s cardiac monitoring system patent is invalid because it didn’t claim an inventive concept, a federal court said.
The patent at the center of the case, U.S. Patent No. 7,941,207, claimed systems and techniques for monitoring cardiac activity. CardioNet alleged InfoBionic’s first- and second-generation cardiac monitoring systems, MoMe Kardia Systems, infringed the patent. But the patent couldn’t be infringed because it was invalid in the first place, Judge Indira Talwani of the U.S. District Court for the District of Massachusetts said.
The question of what’s an abstract idea or law of nature that can’t be patented is ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.